AprilBio Co.,Ltd. (KOSDAQ:397030)

AprilBio Revenue

AprilBio had revenue of 725.35M KRW in the quarter ending March 31, 2026, a decrease of -66.60%. This brings the company's revenue in the last twelve months to 725.35M, down -97.56% year-over-year. In the year 2025, AprilBio had annual revenue of 2.17B, down -92.11%.

• Revenue (ttm): 725.35M
• Revenue Growth: -97.56%
• P/S Ratio: 1,337.98
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 970.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.17B	-25.34B	-92.11%
Dec 31, 2024	27.51B	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	200.00M	-23.20B	-99.15%
Dec 31, 2021	23.40B	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error